Dietary supplement for alleviating the symptoms associated with

Details Dietary supplement for alleviating the symptoms associated with Dietary supplement for alleviating the symptoms associated with

1995-09-12

1996-08-06

Rollins, John W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Conjugate or complex

424464, 424641, 424643, 514458, A61K 3578, A61K 920, A61K 3332

Patent

active

055431461

ABSTRACT:
A composition for a dietary supplement includes: 12.5 to 25% pumpkin seeds by weight; 1,875 to 18.75% extract of Serenoa repens by weight; 6.25 to 12.5% Pygeum africanum by weight; 3.125 to 6.25% zinc glycinate by weight; 3.125 to 9.375% magnesium by weight; and 9,375 to 18.75% vitamin E acetate by weight. The composition may further include Di-Tab, Syloid and magnesium stearate as excipients.

REFERENCES:
patent: 3856946 (1974-12-01), Debat
patent: 4011313 (1977-03-01), Thompson
patent: 4258037 (1981-03-01), Juvin
patent: 5340803 (1994-08-01), Rubin
patent: 5382430 (1995-01-01), Soma et al.
patent: 5405613 (1995-04-01), Rowland
patent: 5411748 (1995-05-01), Song
patent: 5476842 (1995-12-01), Rubin

Affiliated with

Also associated with

Rating

Dietary supplement for alleviating the symptoms associated with does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dietary supplement for alleviating the symptoms associated with , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary supplement for alleviating the symptoms associated with will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2189401